ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Efficacy and Safety of MK-1942 as an Adjunct Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia (MK-1942-008)

ClinicalTrials.gov ID: NCT05602727

Public ClinicalTrials.gov record NCT05602727. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 3:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a/2b Randomized, Placebo-Controlled Clinical Study To Evaluate The Safety And Efficacy Of MK-1942 As Adjunctive Therapy In Participants With Mild To Moderate Alzheimer's Disease Dementia

Study identification

NCT ID
NCT05602727
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
99 participants

Conditions and interventions

Interventions

  • MK-1942 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
55 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 1, 2022
Primary completion
Sep 26, 2023
Completion
Sep 26, 2023
Last update posted
Dec 9, 2024

2022 – 2023

United States locations

U.S. sites
22
U.S. states
15
U.S. cities
22
Facility City State ZIP Site status
Banner Alzheimer's Institute ( Site 0017) Phoenix Arizona 85006
Neurology Center of North Orange County ( Site 0039) Fullerton California 92835
California Neuroscience Research, LLC ( Site 0058) Sherman Oaks California 91403
JEM Research Institute ( Site 0013) Atlantis Florida 33462
Velocity Clinical Research, Hallandale Beach ( Site 0025) Hallandale Florida 33009
K2 Medical Research ( Site 0057) Maitland Florida 32751
Premier Clinical Research Institute ( Site 0038) Miami Florida 33122
Collier Neurologic Specialists ( Site 0045) Naples Florida 34105
Atlanta Center for Medical Research ( Site 0044) Atlanta Georgia 30331
iResearch Atlanta ( Site 0016) Decatur Georgia 30030
Alexian Brothers Medical Center ( Site 0011) Elk Grove Village Illinois 60007
Tandem Clinical Research ( Site 0055) Marrero Louisiana 70072
Global Medical Institutes LLC; Princeton Medical Institute ( Site 0053) Princeton New Jersey 08540
Advanced Memory Research Institute of New Jersey ( Site 0027) Toms River New Jersey 08755
Richmond Behavioral Associates ( Site 0008) Staten Island New York 10314
AMC Research, LLC ( Site 0004) Matthews North Carolina 28105
NeuroScience Research Center ( Site 0009) Canton Ohio 44718
Summit Headlands ( Site 0018) Portland Oregon 97210
Grayline Research Center ( Site 0003) Wichita Falls Texas 76309
The Memory Clinic ( Site 0054) Bennington Vermont 05201
Re:Cognition Health ( Site 0031) Fairfax Virginia 22031
Northwest Clinical Research Center ( Site 0056) Bellevue Washington 98007

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 52 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05602727, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 9, 2024 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05602727 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →